Key Takeaways
- Weak quarter, weather and urban demand to blame: Consolidated revenue grew just 3.1% in INR terms (5.6% constant currency) as delayed and contracted winters hit the Healthcare portfolio and urban consumption slowed.
- Rural resilience is the bright spot: Rural markets outperformed urban for the fourth consecutive quarter, driven by higher real wage growth, and Dabur’s rural growth outpaced urban by 140 bps.
- Market share gains across the board, but at a cost: Dabur gained share in hair oils, home care, oral care, and juices, yet a ~3% price increase was nullified by extra trade schemes and consumer promotions to fight competitive intensity.
- McKinsey hired for a strategic reset: A three-year vision exercise is underway, questioning every business’s right to win, with outcomes that could include M&A, divestment, or exiting categories.
- What to watch next quarter: Whether the promised sequential demand improvement materializes, the pace of margin recovery toward the 20–21% target, and any early signals from the McKinsey review on portfolio reshaping.
Demand Environment
- Weather wrecked the winter portfolio: October and November were the warmest in many years, directly suppressing demand for Chyawanprash, honey, and Lal Tail. The Health Supplements market declined 6%, and while Chyawanprash declined only 3%, the category headwind was severe.
- Urban slowdown, rural holding up: Urban demand showed clear moderation, while rural markets remained resilient. For Dabur, rural outperformed urban by 140 bps because real wage growth is higher in rural areas (up 5%) versus urban (down 7%), putting more money in rural consumers’ hands.
- Food inflation is the wildcard: Management flagged that food inflation at 8% could shift rural spending toward food and away from discretionary categories, making the rural resilience dynamic fragile and worth monitoring.
- Festive season disappointed: Juices and Nectar were impacted by muted festive demand and price-driven competitive intensity, with out-of-home consumption (30–40% of the business) hit by new entrants like energy drinks and Colas.
- Sequential improvement expected, not guaranteed: Management expects demand to improve over the next few months, citing infrastructure investments, a good harvest, and government budget initiatives, but offered no quantification.
Mohit Malhotra: “When the pie remains the same, the growth is hard to get. That's what one is trying to do.”
Portfolio Performance
| Category | Trend | Commentary |
|---|---|---|
| Oral Care | ▲ Strong | Grew 9.1%; Red franchise and Meswak delivered double-digit growth; Gels toothpaste grew 50% YoY; Dabur Oral Care is now #2 brand in modern trade pan India. |
| Hair Oils | ▲ Gaining share | Grew 3.1%; both coconut and perfumed oils grew ahead of category, gaining 125 bps and 236 bps share respectively; overall Hair Oil share at ~18%, highest ever. |
| Home Care | ▲ Mixed | Grew 5%; Odonil grew double digits in volume; Odomos under pressure from cyclones and delayed winters but gained 574 bps share; Sanifresh grew double digits. |
| Skincare | ▲ Steady | Grew 5.6% driven by Gulabari franchise (9% growth); new formats contributed more than 20% to the Gulabari portfolio. |
| Healthcare | ▼ Soft | Flat overall; Health Supplements (Chyawanprash, honey) hit by unfavorable weather; Digestives grew 4% on Hajmola; OTC and Ethicals (Honitus, Shilajit, Health juices) posted high double-digit growth. |
| Beverages | ▼ Weak | Juices and Nectar impacted by muted festive demand and competitive intensity; Nectar, the 70% market share leader, was the most affected segment, concentrated in the 200 ml pack in metro cities. |
| Foods | ▲ Strong | Culinary growing at 30%; Badshah domestic portfolio growing at 15%. |
| International | ▲ Strong | Grew 18.9% in constant currency, with double-digit growth in Middle East, North Africa, Egypt, UK, US, and Bangladesh; currency devaluations in Egypt, Nigeria, and Bangladesh impacted translated growth. |
- Honey’s specific issue: Crystallization problems that had plagued the category are now resolved, and Dabur holds a 54% exit market share.
- Babool continues to struggle: Babool toothpaste declined this quarter, and management acknowledged it has not been able to improve its performance.
- Chyawanprash post-COVID headwind: Penetration has been under pressure since COVID; Dabur is responding with modern formats (tablets, liquid, powder, capsules) and target-group expansion products like Khajurprash, Kesarprash, and sugar-free variants, which now contribute 20% of the portfolio.
Mohit Malhotra: “So, we are trying to come out with modern formats of Chyawanprash. like tablets, liquid, powder Chyawanprash, capsules of Chyawanprash, whole format extension. That is underway and that is doing well.”
Competitive Intensity & Pricing
- Price increases neutralized by trade spend: A ~3% price increase was taken but was fully offset by extra trade schemes and consumer promotions because consumer demand was low and competitive intensity was high. In Home Care, volume growth of 15–16% translated to only ~5% value growth, with a 10-percentage-point delta consumed fighting the market leader.
- Beverage RPI worsened: The relative price index versus Colas moved from ~2 to ~2.7, making juices less competitive on price. Management’s three-pronged response: a communication revamp educating consumers that Colas are “sin products,” a consumer offer reducing nectar from ₹130 to ~₹100, and a new economical range with RPI of ~2.
- Advertising spend pulled back deliberately: With the category pie not expanding, management considers it futile to spend heavily on advertising when growth is hard to get. The strategy is to consolidate when the pie is static and double down when market growth returns. Overheads are growing mid-single digit while the top line grows low single digit, so money is being conserved to protect margins.
- Inflation mitigation plan: Management expects ~5% inflation to be mitigated through calibrated price increases and cost-saving initiatives under the Samriddhi program. Over the last 5–6 quarters, pricing has broadly been in sync with inflation, though with a time lag.
Oral Care: The Standout Engine
- Herbal tailwind strengthening: The herbal toothpaste category’s saliency improved from 30% to ~32%, and the herbal category grew 7% versus 5% for non-herbal. Dabur Red is riding this tailwind directly.
- IDA accreditation is a moat-builder: Dabur Red became the first Ayurvedic toothpaste accredited by the Indian Dental Association, which previously only accredited fluoride-based toothpastes. This unlocks dentist endorsements and doctor advocacy, a channel previously closed to the brand.
- Gels are scaling fast: The Gels portfolio grew 50% year-on-year and is expected to exit at ₹44–50 crore. Meswak grew 16%, supported by celebrity endorser Nagarjuna in the South.
- Packaging revamp and share of voice: A packaging revamp for Dabur Red is planned for the coming fiscal year to make it more modern-trade-centric. Management acknowledged that share of voice has been lower than market share and committed to increasing it next year.
- Gaps being plugged: Dabur is working to fill portfolio gaps in sensitive, bleeding gums, and whitening segments, with launches expected in the next season.
Mohit Malhotra: “For the first time they have given accreditation to a non-fluoride-based toothpaste. So, now we can get into dentist endorsements also and as we continue the efforts of doctor advocacy, this will also get leveraged...”
McKinsey Strategic Review
- A validation exercise, not just a plan: Management hired McKinsey & Company to refine and align strategy for the next three years, shortening the vision cycle from four years to three due to a volatile geopolitical landscape and uncertain macroeconomic indicators. The exercise has begun and is expected to conclude by the end of the fiscal year.
- Every business is being questioned: The review covers all categories with a special focus on beverages and DCPs. Categories without a right to win will face debate on whether to retain, size down, reduce investments, or exit.
- M&A and divestment are on the table: Management explicitly stated that outcomes could include M&A into categories where Dabur is not present, divestment of existing businesses, or decisions not to invest further in certain areas.
- Separate from prior tactical work: This is distinct from a tactical Revenue Growth Management exercise on Oral Care and Hair Care done six months ago. The McKinsey engagement is strategic and top-level, and will dovetail into next year’s budgeting.
- Consultant payout not yet linked to targets: When asked whether McKinsey’s compensation is tied to achieving the plan’s targets, management said that linkage is not currently in place and will be contemplated only after the exercise concludes.
Mohit Malhotra: “Anything which doesn't have a right to win they will be questioning and there will be a debate happening between management and them to retain or to size down or to reduce investments or what to do.”
Margins & Profitability
- Margins held, but with effort: Management stated it will maintain current margins and aims to reach 20–21% levels, with improvement coming from price increases and cost-saving initiatives.
- Four levers identified: Premium mix improvement, premiumization across categories, cost-saving initiatives under Samriddhi, and calibrated price increases.
- International business profitability improving: Legal costs in the Namaste business are coming down from ₹100 crore to ₹75 crore following an agency change, with some recovery from insurers. Dollar-denominated currencies are performing better, and the Middle East and North Africa region is doing well. The ₹81 crore translation loss from currency devaluations is expected to decline.
- FY26 margin intent is directional only: Management declined to give a margin range for FY26, saying the annual budget is still being prepared. The directional intent is to maintain margins but slightly improve; if there is significant improvement, the excess will be reinvested into advertising.
Mohit Malhotra: “Our attempt will be to go to around 20-21% levels. That's what we were aiming at.”
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Demand recovery | Sequential improvement in demand, backed by infrastructure investments, good harvest, and government budget initiatives | Next few months |
| Q4 revenue growth | Mid-single digit topline growth; sequential improvement over Q3 | Q4 FY25 |
| Q4 margins | Maintain current margins | Q4 FY25 |
| Margin target | Reach 20–21% levels via price increases and cost savings | No date (aspirational) |
| FY26 margin intent | Maintain margins but slightly improve; excess reinvested into advertising | FY26 |
| Inflation mitigation | ~5% inflation mitigated by calibrated price increases and cost-saving initiatives | Ongoing |
| Oral Care packaging revamp | Dabur Red packaging modernized for modern trade | Coming fiscal year |
| Oral Care gap-filling | Launches in sensitive, bleeding gums, and whitening segments | Next season |
| Beverage recovery | Three-pronged strategy: communication revamp, consumer offer on nectar, new economical range | Upcoming season |
| Chyawanprash all-weather positioning | Monsoon campaign and memory-enhancing campaign to reduce seasonality | No date |
| Lal Tail recovery | Rate disturbance from consumer offer to be fully ironed out; new variant launch planned | Next quarter / upcoming season |
| McKinsey strategy exercise | Three-year vision covering all categories, with outcomes potentially including M&A, divestment, or exits | Conclude by end of fiscal year |
| Siens range scale-up | Currently a proof-of-concept on e-commerce; scale-up planned | Later (no date) |
Key Metrics
| Metric | Q3 FY25 |
|---|---|
| Consolidated revenue growth | 3.1% in INR terms, 5.6% in constant currency terms |
| India business revenue growth | 1.7%, underpinned by volume growth of around 1.5% |
| International business growth | 18.9% in constant currency terms |
| Operating profit growth | 2.1% YoY |
| PAT growth | 1.8% YoY |
| HPC portfolio growth | 5.7% |
| Oral Care portfolio growth | 9.1% |
| Hair Oil portfolio growth | 3.1% YoY |
| Home Care growth | 5% YoY |
| Skincare portfolio growth | 5.6% |
| Healthcare portfolio | Flat |
| Digestives growth | 4% |
| Foods: Culinary domestic portfolio growth | 30% |
| Foods: Badshah domestic portfolio growth | 15% |
| India business volume growth | 1.5% |
| Urban business growth | 0.6% |
| Rural business growth | 2% |
| Overall Hair Oil market share | ~18%, highest ever |
| Honey exit market share | 54% |
| Juices and Nectar category market share gain | 320 bps |
| Emerging channels share of India business | More than 20% |
| Advertising spend as percentage of consumer care business | More than 7% |
| Inflation YTD | ~3%; going forward expected ~5% |
| Namaste litigation costs | ₹75 cr in current year, down from ₹100 cr last year |
| International business translation loss | ₹81 cr |